AMAlvaro Enrique Marroquin Murcia

Alvaro Enrique Marroquin Murcia

*This is an algorithmically generated author record based on publicly available information.

Alvaro Enrique Marroquin Murcia has a total of 23 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Decoding the Genetic Origins of Neurodevelopmental Disorders: De Novo Variants, Genomic Sequencing, and Precision Approaches to Early Diagnosis

    by Luis Alberto Erosa-De Haro, Camilo José Izquierdo Flores, Eber Marcel Mendoza Osorio, Juan José Vergara Serpa, Alvaro Enrique Marroquin Murcia, Ana Cristina Samaniego Samaniego, Keren Abigail Saynes Jarquin, Elizabeth Parada Sánchez, Karena Espinoza Saavedra, Laura Vanessa Cely Infante, et al.

    Neurodevelopmental disorders represent a heterogeneous group of conditions characterized by alterations in cognitive, behavioral, motor, and neurological development, frequently associated with complex genetic mechanisms. Among these, de novo genetic variants have emerged as major contributors to severe developmental phenotypes, including intellectual disability, global developmental delay, autism spectrum disorder, and developmental epileptic encephalopathies. This review examines the molecular contribution of newly arising genetic variants, the diagnostic performance of next-generation sequencing technologies, genotype–phenotype correlations, and the clinical implications of early molecular identification. A structured narrative review was developed using 20 foundational and contemporary scientific publications, complemented by recent evidence concerning clinical utility, with particular attention to international investigations and Latin American contributions. The reviewed evidence indicates that pathogenic de novo coding variants account for an estimated 42% of severe developmental disorders in a major genomic cohort, while exome sequencing demonstrates an overall diagnostic yield of approximately 36% across neurodevelopmental populations. Evidence from Brazil further illustrates the relevance of newly arising variants in genetically heterogeneous pediatric cohorts. Molecular findings reveal convergence among genes involved in chromatin remodeling, transcriptional regulation, synaptic organization, and neuronal excitability, highlighting the complexity of genotype–phenotype relationships. Furthermore, positive genomic diagnoses may contribute to modifications in clinical management, although improvements in long-term developmental outcomes remain insufficiently established. Persistent challenges include uncertain variant classification, incomplete molecular characterization, unequal population representation, and limited access to genomic technologies. The integration of genomic sequencing, comprehensive clinical phenotyping, genetic counseling, and multidisciplinary pediatric care constitutes a fundamental strategy for improving etiological diagnosis and supporting individualized management. Expanded international collaboration and longitudinal research are necessary to strengthen clinical translation and equitable access to precision genomic medicine.

  • Open Access

    Beyond Cutaneous Injury: Immunopathogenesis, Early Recognition, and Therapeutic Challenges in DRESS and Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis

    by Ana Camila Subia Sandoval, Alberto Escamilla Huerta, Oscar Emmanuel Garcia Moreno, Javier Emanuel Camacho-Patiño, Velbeth Elizabeth Recinos Martínez, Omar Abdel Orellana Arévalo, Guillermo Andres Díaz León, José Rodrigo Roca Alvarez, Alvaro Enrique Marroquin Murcia

    Severe cutaneous adverse drug reactions represent a major clinical challenge due to their complex immunological mechanisms, heterogeneous manifestations, and potential to cause life-threatening systemic complications. This narrative review examines the immunopathogenesis, early recognition, diagnostic assessment, and therapeutic management of drug reaction with eosinophilia and systemic symptoms (DRESS) and Stevens–Johnson syndrome/toxic epidermal necrolysis (SJS/TEN). Twenty scientific publications, including clinical investigations, systematic reviews, and international consensus recommendations, were analyzed through a qualitative synthesis incorporating contributions from Latin America. The findings revealed distinct patterns of immune-mediated injury, characterized by systemic inflammation, T-cell activation, and potential herpesvirus reactivation in DRESS, compared with cytotoxic keratinocyte destruction mediated by granulysin and other inflammatory pathways in SJS/TEN. Clinical evidence emphasized the relevance of early drug withdrawal, multidisciplinary assessment, and standardized instruments, including RegiSCAR, ALDEN, and SCORTEN. Therapeutic investigations identified potentially favorable outcomes associated with selected immunomodulatory interventions, including systemic corticosteroids, cyclosporine, and tumor necrosis factor-alpha inhibitors; however, methodological heterogeneity and limited randomized evidence restrict definitive conclusions regarding comparative effectiveness. Latin American contributions highlighted the importance of regional clinical guidelines and improved access to specialized care. Overall, integrating immunological knowledge with structured clinical assessment and evidence-based management may contribute to earlier recognition and more individualized care. Further multicenter investigations are required to clarify therapeutic effectiveness, identify reliable biomarkers, and improve long-term outcomes.

  • Open Access

    Pediatric Tethered Cord Syndrome: Neurological Progression, Functional Evaluation, and Evidence-Based Decision-Making for Neurosurgical Release

    by Marcos Manuel Vásquez Mendoza, Katherine Paola Hidalgo Chuquimarca, Erika Romina Cuenca Riascos, Carlos Andrés Calderón Ramos, Ana Cristina Samaniego Samaniego, Jonathan Alexis Goyes Muñoz, Laura Vanessa Cely Infante, Alvaro Enrique Marroquin Murcia

    Pediatric tethered cord syndrome (TCS) is a complex neurological condition characterized by abnormal spinal cord fixation and pathological traction that may lead to progressive motor, sensory, musculoskeletal, and autonomic dysfunction. Its heterogeneous clinical presentation and variable natural history create significant challenges in early recognition, functional assessment, and surgical decision-making. This narrative review aimed to analyze the neurological manifestations, diagnostic strategies, and clinical criteria supporting neurosurgical untethering in pediatric populations, incorporating international scientific evidence and contributions from Latin America. A descriptive and analytical review of 20 scientific publications addressing pediatric TCS was organized according to the principles of the scientific method, emphasizing clinical presentation, anatomical abnormalities, functional evaluation, surgical indications, and postoperative outcomes. The reviewed evidence demonstrated considerable variability in neurological manifestations, with motor deficits, urinary dysfunction, and musculoskeletal abnormalities representing recurrent clinical findings. Magnetic resonance imaging provided essential anatomical information, while neurological examination and urodynamic assessment contributed complementary functional evidence. Surgical investigations reported favorable neurological stabilization or improvement in selected patients, with effectiveness rates ranging from 65% to 91% across different anatomical categories in one large pediatric cohort. Another investigation documented postoperative improvement in bladder and sensorimotor function in 48% and 42% of patients with corresponding preoperative deficits, respectively. Postoperative complications were generally infrequent within individual categories, although recurrent tethering remained a relevant long-term concern. Considerable uncertainty persists regarding prophylactic surgery in asymptomatic children, optimal intervention timing, and standardized functional outcome measures. Overall, the findings support an individualized, multidisciplinary approach integrating clinical progression, neurological examination, imaging, and functional assessment to guide neurosurgical decisions. Further prospective and multicenter investigations, particularly involving Latin American populations, are necessary to refine surgical selection criteria, identify predictors of neurological deterioration, and improve long-term pediatric outcomes.